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Abstract 
Purpose: To study the effects of parenteral nutrition (TPN), ω-3 polyunsaturated fatty acid (PUFA), L-
arginine (Arg), and glutamine on cellular immunity of patients who have done the liver cancer (LC) 
surgery.  
Methods: Seventy-five (75) LC patients were randomly divided into 5 groups (A - E; 15 cases each), 
group A, B, C, D and E, in which patients were treated with TPN, TPN + fish oil, TPN + Arg, TPN + 
glutamine, and TPN + ω-3 PUFA + Arg + glutamine, respectively. Before and after surgery, CD3 +, CD4 
+ and CD8 + were measured by antibody-sensitized erythrocyte rosette test, and IL-6, IL-10 and TNF-a 
were assayed with double-antibody sandwich enzyme-linked immunoassay (DAS-ELISA). IgA and IgM 
were measured nephelometrically. 
Results: The levels of CD3 +, CD4 + and CD8 + in group A showed no obvious change after surgery (p 
> 0.05). However, CD3 + and CD4 + increased in groups B, C and D, while CD8 + decreased in group 
E (p < 0.05). IL-6 in group E was lower than that in any of the other four groups (p < 0.05). IL-10 in 
group A was lower than that in groups B, C and D, but lower than in group E (p < 0.05). The levels of 
TNF-a in groups B and C were lower than those in group A, but higher than that in group E (p < 0.05) 
but lower than in group D. IgA in group E was higher than in the other groups (p < 0.05), while IgM level 
in group E was lower than in groups A, B and C (p < 0.05).  
Conclusion: Immunosuppressive status and cellular immunity of patients after liver cancer surgery may 
be improved by a combination therapy of TPN, ω-3 PUFAs, Arg and glutamine. 
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Patients with malignant tumors often suffer from 
malnutrition and immune disfunction. Trauma 
and post-operative stress response further lower 
immunity, which often result in poor outcomes 
and failure of operation [1]. Parenteral nutrition 
(TPN) can improve the nutritional status of 
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postoperative patients, but it cannot restore 
immunity. However, immune nutrition (the 
addition of immune nutrient preparations to TPN) 
can provide postoperative patients with adequate 
nutrition and inflammation elimination while 
boosting their immune levels [2]. ω-3 fatty acids 
and glutamine are common immune nutrients.  
 
In this study, ω-3 unsaturated fatty acids, 
arginine and glutamine were selected as immune 
preparations, and the influences of which on 
cellular immune status of patients after liver 




General information on subjects  
 
In this study, 75 liver cancer patients hospitalized 
from 2014 to 2016, were selected as study 
subjects, who were diagnosed with liver cancer 
through CT, serum AFP examination, and liver 
biopsy, and who were made up of 45 males and 
30 females, aged 40 - 68 years (mean age, 45.8 
± 7.2 years). There were 35, 30 and 10 cases of 
tumors in the left liver, right liver, and the middle 
lobe of the liver respectively. Inclusion criteria 
were: absence of metabolic, infectious and 
inflammatory bowel diseases; normal liver and 
kidney functions; absence of other malignant 
tumors; non-usage of steroids and 
immunosuppressive agents within 1 month prior 
to the operation, and non-administration of 
chemotherapy. Additionally, each patient signed 
a written informed consent to the participation in 
the study [3]. Patients who did not meet these 
inclusion criteria were excluded from the study. 
 
Study methods  
 
The patients in this study were randomly divided 
into five groups (A – E), with 15 patients in each 
one. Patients in group A were treated with TPN, 
while those in group B, C, D and E received TPN 
+ fish oil, TPN + Arg, TPN + glutamine and TPN 
+ ω-3 PUFA + Arg + glutamine respectively. 
Twenty (20) patients undergoing open 
cholecystectomy were selected as control group 
(with normal immune levels). No significant 
difference was found in age, sex, number of T-
cell sub-types, cellular inflammatory factors and 
immunoglobulin among the 5 experimental 
groups. 
 
Composition and dosage of TPN  
 
TPN was administered to patients after surgery 
through a central venous catheter placed across 
the subclavian vein during the operation. The 
total input procedure was 6 days. In accordance 
with the nutrition calculation rule, the daily 
supplemental energy was 30 kcal/kg and the 
nitrogen source intake was 0.20 g/kg/day, which 
could guarantee patients’ the daily normal 
nutritional requirement. Compounded by a 
nutritionist, TPN contained 10 % Compound 
Amino Acid Injection (Wuxi Huarui Company), 20 
% Lipofundin (fat emulsion; Braun, Germany) 
and intravenous glucose (50, 10 and 5 %); in 
addition to daily intake of adequate vitamins and 
trace elements. The immune nutrition 
preparations consisted of ω-3 fish oil, Fat 
Emulsion Injection (Austria Fresenius Kabi 
Austria GmbH), 25 g L-Arg/day (Shanghai 
Biochemical Pharmaceutical Factory), and 0.4 g 
glutamine/kg/day (Jiangsu Shenhua 
Pharmaceutical Co, Ltd), all of which were mixed 
prior to packaging and presentation. 
 
Evaluation of biochemical indices 
 
Following manufacturer’s instructions, T-cell sub-
types CD3 +, CD4 +, CD8 + were assayed with 
antibody sensitized erythrocyte rosette kits; 
cellular inflammatory factors IL-6 and IL-10 were 
determined by applying double antibody 
sandwich (DAS)-ELISA (Shenzhen Jingmei 
Company). TNF-a was assayed with TNF-a kit 
(Shanghai Xinyu Company), while IgA and IgM 
levels were determined by nephelometric assay 
by using kits (American Dade Behring 
Company). 
 
Ethical approval for the human studies was given 
by Ethical Committee of Baoding Second 
Hospital (approval no. 20170101 and the 
experiments followed international guidelines for 
human studies [4].  
 
Statistical analysis  
 
The data are expressed in percentage, and 
differences were analyzed by t-test. Numerical 
data are presented as mean ± standard deviation 
(SD), and were analyzed by Chi square test 
using SPSS version 18. P < 0.05 was taken as 




Levels of T-lymphocyte subsets in patients 
 
The levels of CD3 + and CD4 + in the liver 
cancer patients were clearly lower than those of 
the control group, while CD8 + was higher (p < 
0.05), which indicated that the cellular immunity 
of patients with pre-operative liver cancer (PLC) 
was lower than that of the control group (Table 
1).  
 
Zhixue et al 
509 
 
Table 1: T- cell subsets in pre-operative (PLC) 
patients 
 
Group N CD3 + CD4 + CD8 + 












t value  -11.66 13.88 -7.42 
p value  <0.01 <0.01 <0.01 
Note: Values of T-lymphocyte sub-types are 
expressed as mean ± SD 
 
Levels of T-cell sub-types in patients after 
surgery 
 
The levels of CD3 +, CD4 + and CD8 + in group 
A were of no great difference from their 
corresponding values prior to surgery (p > 0.05), 
but significantly changed after the operation in 
the other groups (p < 0.05), which indicates that 
TPN and immune nutrient preparation effectively 
improved patients’ immunity. The CD3 + and 
CD4 + levels in group E were significantly higher 
than those in group B, C, D (Table 2), showing 
that the effect by mixing ω-3 unsaturated fatty 
acids, Arg and glutamine, was better than that by 
using these components separately. 
 
Table 2: Number of T-cell subs-types in patients post-
surgery 
 


































Note: Values are mean ± SD. * p < 0.05 compared 
with pre-operative group; # p < 0.05 compared with 
group, &p < 0.05 compared with group E.   A: Patients 
received TPN. B: Patients received TPN + fish oil. C: 
Patients received TPN + Arg. D: Patients received 
TPN + glutamine. E: Patients received TPN + ω-3 
PUFA + Arg + glutamine 
 
Levels of cellular inflammatory factors in 
patients post-operation 
No significant difference was in the levels of IL-6 
in B, C, and D relative to group A (p > 0.05), but 
IL-6 in group E was obviously lower (p < 0.05). 
Higher amounts of IL-10 were seen in group B, C 
and D when compared to group A (p < 0.05), the 
level of which in E group was significantly higher 
(p < 0.05). Besides, significantly lower levels of 
TNF-a were obtained in group B and C than in 
group A (p < 0.05). The level of TNF-a in group D 
was significantly higher than that in group E. 
 
Table 3: Cytokine levels of patients after operation 
 



































Note: Values are mean ± SD. * p < 0.05 compared 
with preoperative group; # p < 0.05 compared with 
group A; &p < 0.05 compared with group E. A: Patients 
received TPN. B: Patients received TPN + fish oil. C: 
Patients received TPN + Arg. D: Patients received 
TPN + glutamine. E: Patients received TPN + ω-3 
PUFA + Arg + glutamine 
     
Immunoglobulin content of patients after 
operation 
 
Group E had significantly higher IgA than the 
pre-operative group as well as any of the other 
four groups (p < 0.05. The IgA content had no 
significant difference between group A and group 
B, C and D (p > 0.05). The content of IgM in 
group E was clearly lower than that in group A, B 
and D (p < 0.05). These results are shown in 
Table 4. 
  
Table 4: Immunoglobulin levels in the 5 groups after 
operation 
 
Group IgA (g/L) IgM (g/L) 
Before 
operation 
2.25 ± 0.58 1.40 ± 0.30 
A 2.20 ± 0.67& 1.38 ± 0.44& 
B 2.53 ± 0.73& 1.23 ± 0.28& 
C 2.44 ± 0.86& 1.03 ± 0.26*# 
D 2.56 ± 0.82& 1.24 ± 0.22& 
E  2.94 ± 0.71*# 1.08 ± 0.23*# 
Note: Values are mean ± SD; *p < 0.05 in comparison 
with pre-operative group; #p < 0.05 compared with 
group A; &p < 0.05 in comparison with group E. A: 
Patients received TPN; B: Patients received TPN + 
fish oil; C: Patients received TPN + Arg; D: Patients 
received TPN + glutamine; E: Patients received TPN + 




The normal immune function of the human body 
is maintained by cellular immunity and humoral 
immunity. The immune system of post-operative 
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patients with malignant tumor can be easily 
affected by such factors as surgical trauma, 
drugs and malnutrition, although the suppressed 
immune function is gradually restored to normal 
1 month after surgery [5]. What’s the problem is 
that the reduced immunity affects the healing of 
surgical wounds, may causing post-operative 
infection and complications. Thus, it is of crucial 
to provide adequate immune and nutritional 
support for patients during the post-operative 
stage, owing to the fact that nutritional support is 
conducive to patients’ recovery, status 
improvement and further treatment. Studies have 
demonstrated that T-lymphocyte sub-types and 
serum cytokines are important indicators of the 
immune system [6]. This study investigated the 
effect of added immune nutrients on cellular 
immunity. 
 
Deep sea fish oil is rich in ω-3 unsaturated fatty 
acids which can enhance patients’ humoral and 
cellular immune functions, and effectively resist 
inflammatory reactions. Unsaturated fatty acids 
as precursors of prostaglandins, are important 
components of cell membranes, which maintain 
the fluidity of cell membranes, and participate in 
the regulation of cellular and biochemical 
responses [7]. Fish oil/kg body weight/day (0.2 g) 
in addition to TPN has been recommended to be 
taken by gastrointestinal tumor patients after 
surgery, for reduction of inflammatory response 
syndrome and post-operative recovery, on the 
basis of the fact that ω-3 unsaturated fatty acids 
inhibit the formation of pro-inflammatory factors 
(IL-6 and TNF-a), increase the synthesis of anti-
inflammatory factor IL-10, improve immune 
function and eliminate excessive inflammation 
[8,9]. 
 
As a major component of the mucosal defense 
system and an important protective barrier, IgA 
slows down viral proliferation. Appearing in the 
first humoral immune response, IgM is a marker 
of infection. T-lymphocytes are the most 
important immune cells in the human body; CD3 
+ represents mature T cells and the overall 
immune level, while CD4 + stimulates T-
lymphocytes directly involved in the immune 
process, enhancing immunity. On the other hand, 
CD8 + is a scavenger in the immune process: 
which removes infected cells, and of which the 
main role is to suppress immunity. These three 
immune cells oppose one another, and together 
balance the immune system [10]. 
Studies have shown that glutamine 
supplementation in tumor patients after operation 
can inhibit the expression of TH-related 
cytokines, decrease endotoxin translocation and 
the incidence of post-operative infection, 
increase glutathione synthesis, and shorten 
recovery period [11]. In the current study, 
glutamine supplementation in TPN significantly 
increased CD3 + and CD4 + levels, and 
decreased CD8 + content, compared with their 
corresponding values before surgery. 
Participates in the regulation of immunity, 
Arginine (Arg), an essential amino acid and a 
source of citrulline and nitric oxide in the body, 
promotes the production of Il-6 and TNF-a by T-
lymphocytes. Nitric oxide is a messenger 
molecule involved in mediating many immune 
responses [12,13].  
 
Studies have also shown that animals infected 
with bacteria can improve lymphocyte immune 
function and survival rate after Arg 
supplementation [14]. In this study, it was found 
that addition of Arg to TPN significantly increased 
the production of anti-inflammatory factor IL-
10and the synthesis of CD3 + and CD4 +; but 
decreased the levels of bacterial killer CD8 +. 
The levels of CD3 + and CD4 + in the liver 
cancer patients were significantly lower, but the 
level of CD8 + was higher, than those of the 
control group, which clearly indicates that the 
cellular immune level of the pre-operative liver 
cancer patients was lower than that of the control 
one.  
 
The pattern of changes in the levels of anti-
inflammatory factors, cytokines and 
immunoglobulins in the five groups relative to the 
pre-operative group clearly signifies an 
improvement in cellular immunity of the post-
operative liver cancer patients by incorporation of 
ω-3 PUFA, Arg and glutamine into TPN. 
 
Limitations of the study 
 
Few participants were included in this research. 
What’s more, this is a single-center study. 
Therefore, caution should be exercised in 




The findings of this investigation show that the 
combined use of TPN, ω-3 polyunsaturated fatty 
acids, arginine and glutamine is more effective 
than the individual compounds in improving 
cellular immunity levels and reducing 
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